Skip to content
10-Q

Quarterly Report

Envoy Medical, Inc. COCH COCHW

0001213900-25-107902

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 28.79M sh
Shares Diluted Q3 2025 · Sep 30, 2025 21.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 21.52M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 18.62M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 18.61M sh
Dividends Paid Q3 2025 · Sep 30, 2025 $1.82M
Dividends Paid Q3 2025 · Sep 30, 2024 $1.83M
Capex Q3 2025 · Sep 30, 2025 $7K
Capex Q3 2025 · Sep 30, 2024 $1.51M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$12.52M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$12.86M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$7.66M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$29.86M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$24.22M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$18.84M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$18.54M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$12.4M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$7.43M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$1.78M
Current Liabilities Q3 2025 · Sep 30, 2025 $8.99M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.54M
Total Liabilities Q3 2025 · Sep 30, 2025 $15.71M
Total Liabilities Q3 2025 · Dec 31, 2024 $30.38M
Current Assets Q3 2025 · Sep 30, 2025 $5.76M
Current Assets Q3 2025 · Dec 31, 2024 $8.9M
Total Assets Q3 2025 · Sep 30, 2025 $8.18M
Total Assets Q3 2025 · Dec 31, 2024 $11.54M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.97
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.39
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1.09
Eps Basic Q3 2025 · Sep 30, 2025 −$0.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.97
Eps Basic restated Q3 2025 · Sep 30, 2024 −$0.39
Eps Basic restated Q3 2025 · Sep 30, 2024 −$1.09
Rd Expense Q3 2025 · Sep 30, 2025 $2.7M
Rd Expense Q3 2025 · Sep 30, 2025 $7.93M
Rd Expense Q3 2025 · Sep 30, 2024 $2.76M
Rd Expense Q3 2025 · Sep 30, 2024 $7.71M
Net Income Q3 2025 · Sep 30, 2025 −$6.48M
Net Income Q3 2025 · Sep 30, 2025 −$17.17M
Net Income Q3 2025 · Jun 30, 2025 −$5.69M
Net Income Q3 2025 · Mar 31, 2025 −$5M
Net Income Q3 2025 · Sep 30, 2024 −$5.96M
Net Income Q3 2025 · Sep 30, 2024 −$16.18M
Net Income Q3 2025 · Jun 30, 2024 −$3.95M
Net Income Q3 2025 · Mar 31, 2024 −$6.27M
Operating Income Q3 2025 · Sep 30, 2025 −$5.71M
Operating Income Q3 2025 · Sep 30, 2025 −$15.89M
Operating Income restated Q3 2025 · Sep 30, 2024 −$4.97M
Operating Income restated Q3 2025 · Sep 30, 2024 −$14.71M
Revenue Q3 2025 · Sep 30, 2025 $42K
Revenue Q3 2025 · Sep 30, 2025 $166K
Revenue Q3 2025 · Sep 30, 2024 $56K
Revenue Q3 2025 · Sep 30, 2024 $183K